Natera
NTRA
#689
Rank
C$46.62 B
Marketcap
C$337.85
Share price
1.03%
Change (1 day)
42.56%
Change (1 year)

Revenue for Natera (NTRA)

Revenue in 2025 (TTM): C$2.97 Billion

According to Natera's latest financial reports the company's current revenue (TTM ) is C$2.92 Billion. In 2024 the company made a revenue of C$2.43 Billion an increase over the revenue in the year 2023 that were of C$1.43 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Natera from 2014 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) C$2.97 B22.11%
2024 C$2.43 B69.59%
2023 C$1.43 B29.01%
2022 C$1.11 B39.62%
2021 C$0.79 B59.89%
2020 C$0.49 B26.26%
2019 C$0.39 B12.5%
2018 C$0.35 B32.09%
2017 C$0.26 B-8.92%
2016 C$0.29 B10.47%
2015 C$0.26 B42.85%
2014 C$0.18 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Prothena
PRTA
C$16.28 M-99.44%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Paratek Pharmaceuticals
PRTK
C$0.23 B-92.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$16.19 B 453.85%๐Ÿ‡บ๐Ÿ‡ธ USA